يعرض 1 - 14 نتائج من 14 نتيجة بحث عن '"surgical infection/pc [Prevention]"', وقت الاستعلام: 0.40s تنقيح النتائج
  1. 1
    Electronic Resource
  2. 2
    Electronic Resource
  3. 3
    Electronic Resource
  4. 4
    Electronic Resource
  5. 5
    Electronic Resource
  6. 6
    Electronic Resource
  7. 7
    Electronic Resource
  8. 8
    Electronic Resource

    المؤلفون: Street A.C., Woolley I.J., Love R.L.

    مصطلحات الفهرس: cefalotin/dt [Drug Therapy], Clostridium septicum, comminuted fracture/su [Surgery], drug use, erythema, falling, fever, fracture healing, gas gangrene, Gram staining, hospital discharge, human, human cell, male, medical literature, open reduction, osteosynthesis, postoperative pain/co [Complication], priority journal, superinfection/co [Complication], superinfection/di [Diagnosis], superinfection/dt [Drug Therapy], superinfection/pc [Prevention], surgical infection/co [Complication], surgical infection/di [Diagnosis], surgical infection/dt [Drug Therapy], surgical infection/pc [Prevention], tibia fracture/su [Surgery], wound infection/co [Complication], wound infection/di [Diagnosis], wound infection/dt [Drug Therapy], wound infection/pc [Prevention], amoxicillin/dt [Drug Therapy], cefalexin/dt [Drug Therapy], cefalexin/po [Oral Drug Administration], penicillin derivative/cm [Drug Comparison], penicillin derivative/dt [Drug Therapy], penicillin G/dt [Drug Therapy], gentamicin/iv [Intravenous Drug Administration], gentamicin/dt [Drug Therapy], flucloxacillin/iv [Intravenous Drug Administration], flucloxacillin/dt [Drug Therapy], cephalosporin derivative/dt [Drug Therapy], cephalosporin derivative/cm [Drug Comparison], cefalotin/iv [Intravenous Drug Administration], adult, ankle edema, antibiotic prophylaxis, article, bacteremia/co [Complication], bacteremia/di [Diagnosis], bacteremia/dt [Drug Therapy], bacteremia/pc [Prevention], bacterium culture, blood culture, case report, chill, Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32511
    Click here for full text options
    LibKey Link

  9. 9
  10. 10
    Electronic Resource
  11. 11
    Electronic Resource

    المؤلفون: Street A.C., Woolley I.J., Love R.L.

    مصطلحات الفهرس: cefalotin/dt [Drug Therapy], Clostridium septicum, comminuted fracture/su [Surgery], drug use, erythema, falling, fever, fracture healing, gas gangrene, Gram staining, hospital discharge, human, human cell, male, medical literature, open reduction, osteosynthesis, postoperative pain/co [Complication], priority journal, superinfection/co [Complication], superinfection/di [Diagnosis], superinfection/dt [Drug Therapy], superinfection/pc [Prevention], surgical infection/co [Complication], surgical infection/di [Diagnosis], surgical infection/dt [Drug Therapy], surgical infection/pc [Prevention], tibia fracture/su [Surgery], wound infection/co [Complication], wound infection/di [Diagnosis], wound infection/dt [Drug Therapy], wound infection/pc [Prevention], amoxicillin/dt [Drug Therapy], cefalexin/dt [Drug Therapy], cefalexin/po [Oral Drug Administration], penicillin derivative/cm [Drug Comparison], penicillin derivative/dt [Drug Therapy], penicillin G/dt [Drug Therapy], gentamicin/iv [Intravenous Drug Administration], gentamicin/dt [Drug Therapy], flucloxacillin/iv [Intravenous Drug Administration], flucloxacillin/dt [Drug Therapy], cephalosporin derivative/dt [Drug Therapy], cephalosporin derivative/cm [Drug Comparison], cefalotin/iv [Intravenous Drug Administration], adult, ankle edema, antibiotic prophylaxis, article, bacteremia/co [Complication], bacteremia/di [Diagnosis], bacteremia/dt [Drug Therapy], bacteremia/pc [Prevention], bacterium culture, blood culture, case report, chill, Article

  12. 12
  13. 13
    Electronic Resource

    مصطلحات الفهرس: antiinfective agent/dt [Drug Therapy], antiinfective agent/pe [Pharmacoeconomics], beta lactam antibiotic/ct [Clinical Trial], beta lactam antibiotic/do [Drug Dose], beta lactam antibiotic/dt [Drug Therapy], beta lactam antibiotic/pe [Pharmacoeconomics], cefalotin/ct [Clinical Trial], cefalotin/do [Drug Dose], cefalotin/dt [Drug Therapy], cefalotin/pe [Pharmacoeconomics], cefazolin/ct [Clinical Trial], cefazolin/do [Drug Dose], cefazolin/dt [Drug Therapy], cefazolin/pe [Pharmacoeconomics], cefotaxime/ct [Clinical Trial], cefotaxime/do [Drug Dose], cefotaxime/dt [Drug Therapy], cefotaxime/pe [Pharmacoeconomics], cefoxitin/ct [Clinical Trial], cefoxitin/do [Drug Dose], cefoxitin/dt [Drug Therapy], cefoxitin/pe [Pharmacoeconomics], cefradine/ct [Clinical Trial], cefradine/do [Drug Dose], cefradine/dt [Drug Therapy], cefradine/pe [Pharmacoeconomics], ceftazidime/ct [Clinical Trial], ceftazidime/do [Drug Dose], ceftazidime/dt [Drug Therapy], ceftazidime/pe [Pharmacoeconomics], cefuroxime/ct [Clinical Trial], cefuroxime/do [Drug Dose], cefuroxime/dt [Drug Therapy], cefuroxime/pe [Pharmacoeconomics], cotrimoxazole/ct [Clinical Trial], cotrimoxazole/do [Drug Dose], cotrimoxazole/dt [Drug Therapy], cotrimoxazole/pe [Pharmacoeconomics], doxycycline/ct [Clinical Trial], doxycycline/do [Drug Dose], doxycycline/dt [Drug Therapy], doxycycline/pe [Pharmacoeconomics], fleroxacin/ct [Clinical Trial], fleroxacin/do [Drug Dose], fleroxacin/dt [Drug Therapy], fleroxacin/pe [Pharmacoeconomics], gentamicin/ct [Clinical Trial], gentamicin/do [Drug Dose], gentamicin/dt [Drug Therapy], gentamicin/pe [Pharmacoeconomics], latamoxef/ct [Clinical Trial], latamoxef/do [Drug Dose], latamoxef/dt [Drug Therapy], latamoxef/pe [Pharmacoeconomics], metronidazole/ct [Clinical Trial], metronidazole/do [Drug Dose], metronidazole/dt [Drug Therapy], metronidazole/pe [Pharmacoeconomics], mezlocillin/ct [Clinical Trial], mezlocillin/do [Drug Dose], mezlocillin/dt [Drug Therapy], mezlocillin/pe [Pharmacoeconomics], piperacillin/ct [Clinical Trial], piperacillin/do [Drug Dose], piperacillin/pe [Pharmacoeconomics], tinidazole/ct [Clinical Trial], tinidazole/do [Drug Dose], tinidazole/dt [Drug Therapy], tinidazole/pe [Pharmacoeconomics], piperacillin/dt [Drug Therapy], antibiotic prophylaxis, clinical trial, dose response, drug efficacy, human, major surgery, postoperative infection/dm [Disease Management], postoperative infection/dt [Drug Therapy], postoperative infection/pc [Prevention], practice guideline, review, surgical infection/dm [Disease Management], surgical infection/dt [Drug Therapy], surgical infection/pc [Prevention], antiinfective agent/ct [Clinical Trial], antiinfective agent/do [Drug Dose], Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33460
    Australian and New Zealand Journal of Surgery
    Click here for full text options
    LibKey Link

  14. 14
    Electronic Resource

    مصطلحات الفهرس: antiinfective agent/dt [Drug Therapy], antiinfective agent/pe [Pharmacoeconomics], beta lactam antibiotic/ct [Clinical Trial], beta lactam antibiotic/do [Drug Dose], beta lactam antibiotic/dt [Drug Therapy], beta lactam antibiotic/pe [Pharmacoeconomics], cefalotin/ct [Clinical Trial], cefalotin/do [Drug Dose], cefalotin/dt [Drug Therapy], cefalotin/pe [Pharmacoeconomics], cefazolin/ct [Clinical Trial], cefazolin/do [Drug Dose], cefazolin/dt [Drug Therapy], cefazolin/pe [Pharmacoeconomics], cefotaxime/ct [Clinical Trial], cefotaxime/do [Drug Dose], cefotaxime/dt [Drug Therapy], cefotaxime/pe [Pharmacoeconomics], cefoxitin/ct [Clinical Trial], cefoxitin/do [Drug Dose], cefoxitin/dt [Drug Therapy], cefoxitin/pe [Pharmacoeconomics], cefradine/ct [Clinical Trial], cefradine/do [Drug Dose], cefradine/dt [Drug Therapy], cefradine/pe [Pharmacoeconomics], ceftazidime/ct [Clinical Trial], ceftazidime/do [Drug Dose], ceftazidime/dt [Drug Therapy], ceftazidime/pe [Pharmacoeconomics], cefuroxime/ct [Clinical Trial], cefuroxime/do [Drug Dose], cefuroxime/dt [Drug Therapy], cefuroxime/pe [Pharmacoeconomics], cotrimoxazole/ct [Clinical Trial], cotrimoxazole/do [Drug Dose], cotrimoxazole/dt [Drug Therapy], cotrimoxazole/pe [Pharmacoeconomics], doxycycline/ct [Clinical Trial], doxycycline/do [Drug Dose], doxycycline/dt [Drug Therapy], doxycycline/pe [Pharmacoeconomics], fleroxacin/ct [Clinical Trial], fleroxacin/do [Drug Dose], fleroxacin/dt [Drug Therapy], fleroxacin/pe [Pharmacoeconomics], gentamicin/ct [Clinical Trial], gentamicin/do [Drug Dose], gentamicin/dt [Drug Therapy], gentamicin/pe [Pharmacoeconomics], latamoxef/ct [Clinical Trial], latamoxef/do [Drug Dose], latamoxef/dt [Drug Therapy], latamoxef/pe [Pharmacoeconomics], metronidazole/ct [Clinical Trial], metronidazole/do [Drug Dose], metronidazole/dt [Drug Therapy], metronidazole/pe [Pharmacoeconomics], mezlocillin/ct [Clinical Trial], mezlocillin/do [Drug Dose], mezlocillin/dt [Drug Therapy], mezlocillin/pe [Pharmacoeconomics], piperacillin/ct [Clinical Trial], piperacillin/do [Drug Dose], piperacillin/pe [Pharmacoeconomics], tinidazole/ct [Clinical Trial], tinidazole/do [Drug Dose], tinidazole/dt [Drug Therapy], tinidazole/pe [Pharmacoeconomics], piperacillin/dt [Drug Therapy], antibiotic prophylaxis, clinical trial, dose response, drug efficacy, human, major surgery, postoperative infection/dm [Disease Management], postoperative infection/dt [Drug Therapy], postoperative infection/pc [Prevention], practice guideline, review, surgical infection/dm [Disease Management], surgical infection/dt [Drug Therapy], surgical infection/pc [Prevention], antiinfective agent/ct [Clinical Trial], antiinfective agent/do [Drug Dose], Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33460
    Australian and New Zealand Journal of Surgery
    Click here for full text options
    LibKey Link